Integra Lifesciences Holdings Corp (IART) ticks all the boxes for top investors with its surprise performance of -6.86% last month.

On Tuesday, Integra Lifesciences Holdings Corp (NASDAQ: IART) was -3.46% down from the session before settling in for the closing price of $34.72. A 52-week range for IART has been $33.24 – $59.33.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 1.17% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 2.99%. With a float of $66.12 million, this company’s outstanding shares have now reached $78.17 million.

In an organization with 5329 employees, it is important to assess its efficiency.

Integra Lifesciences Holdings Corp (IART) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Integra Lifesciences Holdings Corp stocks. The insider ownership of Integra Lifesciences Holdings Corp is 15.47%, while institutional ownership is 84.90%. The most recent insider transaction that took place on Mar 06 ’24, was worth 305,492. In this transaction EVP & President, TT of this company sold 8,348 shares at a rate of $36.59, taking the stock ownership to the 49,893 shares. Before that another transaction happened on Aug 09 ’23, when Company’s SVP, Fin & PAO sold 1,177 for $44.46, making the entire transaction worth $52,329. This insider now owns 23,458 shares in total.

Integra Lifesciences Holdings Corp (IART) Latest Financial update

Going through the last 3-months fiscal report unveiled on the 12/30/2023, it has been observed that the corporation posted $0.89 earnings per share (EPS) during the time that was less than consensus figure (set at $0.9) by -$0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.74 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 2.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.80% during the next five years compared to 3.10% growth over the previous five years of trading.

Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators

You can see what Integra Lifesciences Holdings Corp (IART) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.70. Likewise, its price to free cash flow for the trailing twelve months is 35.87.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.84, a number that is poised to hit 0.55 in the next quarter and is forecasted to reach 3.62 in one year’s time.

Technical Analysis of Integra Lifesciences Holdings Corp (IART)

Let’s dig in a bit further. During the last 5-days, its volume was 0.8 million. That was better than the volume of 0.65 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 58.91%. Additionally, its Average True Range was 1.03.

During the past 100 days, Integra Lifesciences Holdings Corp’s (IART) raw stochastic average was set at 2.34%, which indicates a significant decrease from 8.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.59% in the past 14 days, which was lower than the 37.12% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $39.10, while its 200-day Moving Average is $40.43. However, in the short run, Integra Lifesciences Holdings Corp’s stock first resistance to watch stands at $34.27. Second resistance stands at $35.01. The third major resistance level sits at $35.40. If the price goes on to break the first support level at $33.14, it is likely to go to the next support level at $32.75. The third support level lies at $32.01 if the price breaches the second support level.

Integra Lifesciences Holdings Corp (NASDAQ: IART) Key Stats

There are 78,602K outstanding shares of the company, which has a market capitalization of 2.62 billion. As of now, sales total 1,542 M while income totals 67,740 K. Its latest quarter income was 397,040 K while its last quarter net income were 19,830 K.